In March 2025, the company introduced new options for any direct-to-client giving of its Wegovy weight loss drug. The company recognized a brand new pharmacy, referred to as NovoCare, which would charge consumers $499 per 30 days for entry to the drug, below fifty percent the price of the drug by means of other pharmaceutical distribution networks.